A human iPSC line carrying a de novo PHF21A variant was generated from an infant with epileptic spasms syndrome, providing a new model for studying the disease.
- Open access
Elsevier BV · Cell & Molecular Biology · ISSN 1873-5061, 1876-7753
Rebuilt
Newest first · last 60 days
A human iPSC line carrying a de novo PHF21A variant was generated from an infant with epileptic spasms syndrome, providing a new model for studying the disease.
A doxycycline-inducible p16 INK4a knock-in human embryonic stem cell line was established, showing dose-dependent p16 INK4a and ZsGreen expression upon induction.
Two human iPSC lines modeling mucopolysaccharidosis types IIIA and I with specific pathogenic variants were generated from KOLF2.1J cells.
CRISPR/Cas9 editing successfully corrected the LRRK2 I1371V mutation in a Parkinson's disease patient-derived iPSC line, creating an isogenic control line with confirmed genetic integrity.
A human iPSC line from a SPG46 patient with compound heterozygous GBA2 variants was successfully generated and characterized.
Adenine base editing successfully generated a PKP2 c.1171-2 A>G mutant human embryonic stem cell line, WAe009-A-3W, with preserved pluripotency and normal karyotype.
Inducible hiPSC lines with controlled Progerin expression enable modeling of cellular aging, with successful integration confirmed by PCR and sequencing.
A human iPSC line from a male HCM patient with a heterozygous TPM1 c.644C>T mutation exhibits normal karyotype and differentiation potential.
CRISPR/Cas9 editing created a Brachyury/TBXT-2A-EGFP reporter line in human embryonic stem cells, enabling real-time monitoring of mesodermal differentiation.
A human iPSC line from an asymptomatic woman carrying the GAA c.2051C>A (p.P684Q) variant was successfully generated, exhibiting typical stem cell features and differentiation capacity.
Two human iPSC lines reprogrammed from adult bone marrow MSCs are genomically stable and can differentiate into the three germ layers.
Two iPSC lines from ALS patients with mutations in SQSTM1 and TBK1 genes were successfully established and characterized.
Thirteen high-quality iPSC clones from PBMCs of five donors were generated and extensively characterized using non-integrating Sendai virus.
Two iPSC lines with FTSJ1 frameshift mutations were created, maintaining pluripotency and differentiation capacity, to model X-linked non-syndromic intellectual disability.
A human induced pluripotent stem cell line from an arrhythmogenic cardiomyopathy patient with DSG2 c.2358delA variant was successfully generated and characterized.
A family with heterozygous RPS19 mutation yielded four iPSC lines representing healthy, silent carrier, and DBA individuals, enabling disease modeling.
Two induced pluripotent stem cell lines from hereditary hemorrhagic telangiectasia patients with ACVRL1 mutations were successfully generated and characterized.
CRISPR-Cas9 corrected the KRT5 p.E475G mutation in a human iPSC line from an epidermolysis bullosa simplex patient, restoring the wild-type sequence without off-target effects.
Gene editing created isogenic USH2A-RP patient-derived iPSC lines with both homozygous and heterozygous corrections of the c.2276G > T mutation.
CRISPR/Cpf1 editing of DNM1L in human iPSCs produces a mutant line with normal morphology, stability, and differentiation capacity.
A human induced pluripotent stem cell line from a Kabuki syndrome 1 patient with a frameshift KMT2D mutation was established, enabling disease modeling.
Two human iPSC lines from HypoPP patients carrying the CACNA1S c.1583G>A (p.Arg528His) mutation were generated and characterized for research use.
A new iPSC line from a 70-year-old patient with double primary lung and colon cancers maintains normal karyotype and differentiation capacity.
A human induced pluripotent stem cell line from a nephronophthisis patient with NPHP4 variants exhibits pluripotency and differentiation capacity.
Eleven high-quality human iPSC clones from four donors were generated and extensively validated for genetic stability and pluripotency.
An induced pluripotent stem cell line from a long QT syndrome type 1 patient with the KCNQ1 c.343G > A p.(E115K) variant was successfully generated, maintaining normal cellular characteristics.
Three induced pluripotent stem cell lines were generated from an immune checkpoint inhibitor-induced myocarditis patient, an ICI-treated patient without myocarditis, and a healthy donor.
Journals this month
Topics moving, week to 23 Oct 2026